The current valuation score of Kiora Pharmaceuticals Inc is 8.69, ranking 105 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.96, which is -552.81% below the recent high of 4.34 and -14.71% above the recent low of -1.10.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.